Treatment options for idiopathic multicentric Castleman disease (iMCD) are currently limited,
especially for patients who do not respond or are resistant to interleukin‐6 inhibitors. For the …

This study aimed to investigate the epidemiologic, clinical, pathological characteristics, and
treatment of patients with Castleman disease (CD) in a single center in China. We …

Multicentric Castleman disease (MCD) is a heterogeneous, life-threatening disease. A
subgroup of HIV-negative and HHV-8-negative MCD is defined as idiopathic MCD (iMCD) …

Abstract Human herpesvirus‐8 (HHV‐8) infection is associated with neoplastic and non‐
neoplastic diseases in immunocompromised patients. Kaposi sarcoma (KS) is a common …

Castleman disease (CD) includes rare and intricate lymphoproliferative disorders
characterized by the abnormal growth of lymph nodes and immune system disturbances. It …

Castleman disease (CD), also known as angiofollicular hyperplasia, is a rare disorder
characterized by nonmalignant mediastinal lymph node enlargement provoked by excess …

Castleman disease (CD) has been reported as a group of poorly understood
lymphoproliferative disorders, including unicentric CD (UCD) and idiopathic multicentric CD …

Castleman disease represents a group of rare lymphoproliferative disorders with
heterogeneous manifestations and similar histopathological features. Due to its broad …

Castleman disease (CD) is a rare lymphoproliferative disorder that includes various clinico-
pathological subtypes. According to clinical course CD is divided in unicentric CD (UCD) …

Presentamos el caso de un paciente de 49 años quien debuto con síntomas B, afectación
neurológica, adenopatías difusas y anemia hemolítica autoinmune por anticuerpos …